Skip to content
WeighLab
Grade C

Eviora MD Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

Eviora MD advertises GLP-1 plans "from $149/mo" but its semaglutide, tirzepatide and microdose pages show no price, only "available by consultation", so you find out what you'd pay after the assessment.

Visit Eviora MD Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Not published
Brand-name
Compounded only

The Index scorecard

Eviora MD scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency20/100
Nationwide Access24/100
Formulation Options40/100
Clinical Oversight74/100
Contract Flexibility61/100

Where the value is

  • Says programs are flat-rate, with no consultation charge and no surcharge when your dose changes
  • $0 if a provider doesn't approve you
  • Includes dose titration, structured check-ins and secure messaging with the care team
  • You can cancel the subscription anytime up to 48 hours before the next monthly charge, and it emails you 5 to 7 days before each charge
  • Offers semaglutide, tirzepatide and a lower-dose GLP-1 microdose program

The tradeoffs

  • No program shows a price; the only figure is a "from $149/mo" new-patient offer that isn't tied to a specific medication
  • The pharmacy and the medical group are not named
  • No refunds once medication has been dispensed, and a prescription order can only be canceled within 24 hours
  • Says it offers telehealth nationwide but publishes no list of states
  • The homepage gives different patient counts ("10k+" and "1,743+") with no source for either
  • Compounded semaglutide and tirzepatide are not FDA-approved products

The bottom line

Best for: People who want a provider-led compounded GLP-1 plan with regular check-ins and are willing to get a quote before committing. Eviora MD advertises GLP-1 plans "from $149/mo" but its semaglutide, tirzepatide and microdose pages show no price, only "available by consultation", so you find out what you'd pay after the assessment.

For comparison, read our review of CoreAge Rx, one of our partners. Partners are listed first on our leaderboard; every provider is scored on the same six factors.

Other programs to compare with Eviora MD

These are partners: we may earn a commission if you sign up, at no cost to you.

  • Sprout HealthPartner

    Semaglutide from $149/mo · tirzepatide from $199/mo

    Sprout charges $149 every four weeks for compounded semaglutide and $199 for tirzepatide, or $99 and $149 a month if you prepay a full year.

  • Trimi HealthPartner

    Semaglutide from $175/mo · tirzepatide from $235/mo

    Trimi charges $175 a month for compounded semaglutide and $235 for tirzepatide month to month; the $99 and $125 it advertises are the prices on a prepaid year.

  • OakPartner

    Semaglutide from $250/mo · tirzepatide from $300/mo

    Oak's order form charges $250 a month for compounded semaglutide and $300 for tirzepatide at every dose, with no subscription and brand-name pens on the same menu, while its marketing pages advertise figures from $89 to $190 that the form does not offer.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to Eviora MD's. See the alternatives to Eviora MD.

The 18 programs nearest this one

Pricing, states and verification reflect Eviora MD's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Eviora MD's site. Not medical advice; see our disclosure.

← Back to the value leaderboard